U.S. Water Utilities Stock News

Recent analyst actions around ManpowerGroup (MAN) have pulled the stock into focus. A BMO Capital upgrade was followed by a UBS price target cut, highlighting differing views on margins and the broader labor market. See our latest analysis for ManpowerGroup. Those mixed analyst calls have landed on a stock that has already been under pressure, with a 1 year total shareholder return decline of 47.29% and a 3 year total shareholder return decline of 61.47%. The 90 day share price return decline...

In early January, research analysts at Mizuho Securities and Maxim Group updated their views on Herbalife, citing a turnaround narrative, improved supply chain ties with distributors, and the resolution of prior US regulatory concerns. This shift in external commentary highlights how regulatory clarity and tighter distributor relationships are shaping perceptions of Herbalife’s long-term business model and risk profile. With analysts pointing to regulatory issues being resolved, we’ll now...

MillerKnoll, Inc. recently appointed Claire Spofford, a veteran retail executive and former J.Jill CEO, to its Board of Directors and Compensation Committee, expanding the Board to eleven members, ten of whom are independent. Spofford’s long track record in omnichannel retail, brand-building and operational improvement introduces fresh consumer-focused expertise that could influence how MillerKnoll shapes its product, marketing and compensation decisions. We’ll now examine how Spofford’s...

In recent updates, WEC Energy Group confirmed that the cancellation of a planned data center project did not alter its long-term sales outlook, announced a planned 6.7% quarterly dividend increase for early 2026, and entered into a US$600 million notes offering with major financial institutions. At the same time, WEC reported US$440,000 in Q4 2025 lobbying spend on power and clean energy policy, while several top executives sold shares, offering a window into how the company manages...

On January 7, 2026, Atmus Filtration Technologies entered into an amended and restated credit agreement, expanding its term loan facility to US$1.00 billion and its revolving credit facility to US$500 million, with both maturing in 2031 and supporting the refinancing of existing debt and the Koch Filter acquisition. This enlarged and longer-dated debt structure gives Atmus greater financial flexibility to integrate Koch Filter and fund working capital, while linking borrowing costs and...

State Street (STT) is back in focus after reporting fourth quarter results that topped analyst expectations on revenue and adjusted earnings, and unveiling a new Digital Asset Platform targeting tokenized funds and cash products. See our latest analysis for State Street. The latest earnings beat and Digital Asset Platform launch come after a strong run, with a 90 day share price return of 11.04% and a 1 year total shareholder return of 35.05%. This suggests that longer term momentum has held...

Plexus (PLXS) has drawn fresh attention after a 7.5% move on January 13, 2026, following its Q4 2025 earnings beat on both EPS and revenue, along with higher Q1 2026 EPS guidance. See our latest analysis for Plexus. The strong Q4 report and higher Q1 EPS guidance have arrived alongside firm share price momentum. The 7 day share price return is 14.95% and the 30 day share price return is 18.27%, while the 5 year total shareholder return of 123.91% indicates that longer term holders have...

If you are wondering whether Union Pacific's current share price lines up with its underlying value, this breakdown is designed to give you a clear, no nonsense view. The stock last closed at US$229.49, with recent returns of 0.5% over 7 days, a 2.0% decline over 30 days, a 1.0% decline year to date, 0.3% over 1 year, 18.0% over 3 years, and 23.9% over 5 years. Recent coverage of Union Pacific has focused on its role as a major US freight railroad and how broader market sentiment around...

Aveanna Healthcare Holdings (AVAH) raised its 2025 revenue guidance to a range of US$2.425b to US$2.445b and issued higher preliminary 2026 targets, putting its home based care model firmly in focus for investors. See our latest analysis for Aveanna Healthcare Holdings. Aveanna’s updated guidance comes after a mixed stretch in the market, with a 7 day share price return of 7.33% and a 90 day share price return of a 10.22% decline. Even so, the year to date share price return of 14.11% and a...

In mid-January 2026, Gap Inc. appointed former Paramount executive Pam Kaufman as Executive Vice President and Chief Entertainment Officer, and moved to establish a new Los Angeles office to build its Fashiontainment platform across entertainment, licensing, and cultural collaborations. This signals a push to more tightly weave Gap’s brands into music, film, sports, and gaming ecosystems by turning content, partnerships, and intellectual property into a scaled growth engine. We’ll now...

Landstar System recently announced that it released its fourth-quarter 2025 results on January 28, 2026, followed by a conference call with analysts and investors that same afternoon, with both live and replay access available through its investor relations website. Alongside this earnings communication, a broad group of research firms has reaffirmed coverage of Landstar while revisiting their expectations for the company’s longer-term business trajectory. We’ll explore how this cluster of...

Earlier in January, Cabot Corporation reported a multi-year agreement to supply advanced conductive carbons and dispersions to PowerCo SE for use in electric-vehicle battery electrodes, while also moving to rebalance its board by conditionally resetting director Thierry Vanlancker’s term at the 2026 Annual Meeting. This combination of a long-term EV battery materials partnership and board realignment highlights Cabot’s effort to strengthen its role across the global clean-energy value...

Acuity Inc. has already reported first-quarter 2025 results, with sales rising to US$1,143.7 million and net income reaching US$120.5 million, alongside higher earnings per share from continuing operations versus a year earlier. Over the same period, the company continued to shrink its share count, completing a long-running buyback program that has retired more than a third of its stock by value since 2018, which can meaningfully shape per-share metrics and capital allocation...

Terex stock: event driven snapshot for investors Terex (TEX) is back on watch for many investors after recent trading left the shares at $60.39, with returns of 11.9% over the past month and 9.6% over the past 3 months. See our latest analysis for Terex. That recent 11.9% 1 month share price return and 9.6% 3 month share price return sits alongside a 29.9% 1 year total shareholder return and 65.8% 5 year total shareholder return. This suggests that momentum has been building over time despite...

In the past few days, BofA Securities downgraded Taylor Morrison Home to Neutral from Buy, citing sector pressures from employment, inflation, and heightened competition that could weigh on the builder’s 2026 earnings. This reassessment contrasts with management’s earlier plans for over 100 new community openings in 2026 and targeted closings growth supported by ongoing share repurchases. Next, we’ll examine how BofA’s concerns over weaker 2026 home deliveries could reshape Taylor Morrison...

In recent days, Manhattan Associates announced the commercial launch of its embedded AI Agents across all Manhattan Active solutions, alongside major AI-driven enhancements to Manhattan Active Omni and the appointment of Katie Foote as Senior Vice President and Chief Marketing Officer to lead global marketing. Together, these moves position Manhattan to embed AI more deeply into supply chain and retail workflows while sharpening its go-to-market execution under a seasoned marketing leader...

Iovance Biotherapeutics (IOVA) has moved back into focus after promising clinical trial results and favorable FDA designations, developments that have lifted sentiment around its Tumor Infiltrating Lymphocyte platform and its potential for future growth. See our latest analysis for Iovance Biotherapeutics. The latest 6.3% 1 day share price return to US$2.36 comes after a tougher stretch, with the year to date share price return of 6.35% and a 1 year total shareholder return decline of 60.07%...

William Blair has started covering Enerpac Tool Group (EPAC) with a Market Perform rating, adding a fresh research voice just ahead of the company’s presentation at CJS Securities’ New Ideas for the New Year investor conference. See our latest analysis for Enerpac Tool Group. The William Blair initiation comes after a solid run in the past month, with a 30 day share price return of 9.32%. Over the past year there has been a 7.99% decline in total shareholder return, while the 3 year total...

Why CNO Financial Group Stock Is On Investors’ Radar CNO Financial Group (CNO) is drawing attention after recent trading left the shares with mixed short term returns but strong multi year total returns. This is prompting investors to reassess the insurer’s current valuation. See our latest analysis for CNO Financial Group. At a recent share price of US$41.54, CNO has seen weaker short term share price returns over the past month and year to date. Its one year and multi year total shareholder...

In recent days, UBS upgraded Adient’s rating and highlighted the company’s fiscal 2025 wins of about US$1.20 billion in new China seating contracts, largely with domestic automakers. These gains, combined with higher-margin program wins in Europe, suggest Adient is repositioning its regional mix toward potentially more profitable business lines. We’ll now examine how the China contract momentum, especially with domestic automakers, influences Adient’s broader investment narrative and risk...

Workday Wellness partnership puts Aflac’s benefits tech push in focus Aflac (AFL) has drawn fresh attention after being named a Workday Wellness partner, integrating its supplemental health products with Workday’s AI-driven benefits platform to help employers fine tune offerings and simplify administration. See our latest analysis for Aflac. The Workday Wellness announcement comes as Aflac’s share price sits at US$109.51, with shorter term share price returns relatively muted while the 1 year...

Earlier this month, Lamb Weston Holdings, Inc. confirmed it will close its Munro, Argentina plant, consolidating Latin American production into a newer Mar del Plata facility, while also temporarily curtailing a production line in the Netherlands and providing severance to about 100 affected employees. This manufacturing reshuffle highlights how Lamb Weston is reshaping its global footprint under its Focus to Win plan, with potential implications for cost efficiency, regional supply...

On 13 January 2026, MGIC Investment Corp CEO Timothy J. Mattke sold about 139,000 shares under a Rule 10b5-1 trading plan, generating roughly US$3.68 million in proceeds. This insider sale comes alongside an active share repurchase program and follows a quarter in which MGIC’s earnings per share topped analyst expectations even as revenue came in slightly below forecasts. We’ll now examine how the CEO’s planned stock sale, set against ongoing buybacks, could influence MGIC Investment’s...

In early January 2026, DISCO Pharmaceuticals announced an exclusive license agreement granting Amgen global rights to develop and commercialize novel cancer therapies emerging from DISCO’s surface-proteomics platform, with DISCO eligible for up to US$618 million in potential payments plus royalties. This partnership gives Amgen access to highly specific, surfaceome-directed modalities such as bispecific ADCs and T-cell engagers, potentially enriching its oncology pipeline alongside momentum...